Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Passage Bio, Inc. (PASG) had Non-Operating Income/Expense of $1.05M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-15.40M |
|
-- |
|
-- |
|
$16.46M |
|
$-16.46M |
|
|
Non-Operating Income/Expense |
$1.05M |
$-15.40M |
|
$-15.40M |
|
$-15.40M |
|
$-15.40M |
|
$-15.40M |
|
$-15.40M |
|
$-16.46M |
|
$-16.13M |
|
3.11M |
|
3.11M |
|
$-5.00 |
|
$-5.00 |
|
| Balance Sheet Financials | |
$66.67M |
|
$5.52M |
|
$19.34M |
|
$86.01M |
|
$17.82M |
|
-- |
|
$21.48M |
|
$39.30M |
|
$46.71M |
|
$46.71M |
|
$46.71M |
|
3.11M |
|
| Cash Flow Statement Financials | |
$-13.85M |
|
$39.63M |
|
-- |
|
$37.57M |
|
$63.36M |
|
$25.78M |
|
$0.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.98% |
|
-32.98% |
|
-17.91% |
|
-32.98% |
|
$15.03 |
|
$-4.27 |
|
$-4.46 |
|